Seattle Genetics | Vertriebs- Und Verwaltungskosten



Selling And Administration Expenses Veränderung Datum
AbbVie USD 3.29B 562M 2025-03
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Amgen USD 1.69B 191M 2025-03
Astellas Pharma JPY 211.32B 13.99B 2025-03
Bayer EUR 3.71B 628M 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Celldex Therapeutics USD 10.82M 557K 2025-03
Daiichi Sankyo JPY 208.21B 22.58B 2025-03
Eisai JPY 106.51B 1.99B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Exelixis USD 137.18M 2.86M 2025-04
Genmab DKK 126M 1.12B 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Incyte USD 325.69M 1.02M 2025-03
Insmed USD 147.54M 5.03M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.53B 319M 2025-03
Moderna USD 212M 139M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Sanofi EUR 2.22B 980M 2025-03
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Takeda JPY 295.87B 25.28B 2025-03
Teva Pharmaceutical Industries USD 919M 33M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Xencor USD 17.34M 2.42M 2025-03



Seattle Genetics Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.